| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2009 | US20090117176 Anticancer Treatments |
| 05/07/2009 | US20090117175 Hemostatic compositions and therapeutic regimens |
| 05/07/2009 | US20090117171 Compositions and methods for treatment of macular degeneration and related conditions |
| 05/07/2009 | US20090117167 Injectable capsaicin with vasocontrictor adjunctive agent |
| 05/07/2009 | US20090117163 Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like |
| 05/07/2009 | US20090117160 Compositions for Making up Keratinous Materials |
| 05/07/2009 | US20090117159 Pharmaceutical compositions comprising fesoterodine |
| 05/07/2009 | US20090117156 Gene therapy for niemann-pick disease type a |
| 05/07/2009 | US20090117155 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter |
| 05/07/2009 | US20090117154 Synthetic polyvalent carbohydrates as components of microbicides |
| 05/07/2009 | US20090117151 for preparing a vaccine which contains one or more than two genes among pgs B, pgs C and pgs A encoding poly- gamma -glutamate synthetase complex and genes selected from human papilloma virus (HPV) E6 and HPV E7 antigen protein associated with tumor induction; genital wash |
| 05/07/2009 | US20090117149 Novel attenuated virus strains and uses thereof |
| 05/07/2009 | US20090117139 Lutzomyia longipalpis polypeptides and methods of use |
| 05/07/2009 | US20090117125 Synthesis of 8h-3a-aza-cyclopenta[a]indenes and 5,10-dihydropyrrolo[1,2-b]isoquinolines derivatives and their use as antitumor therapeutic agents |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117107 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 05/07/2009 | US20090117099 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/07/2009 | US20090117083 Immunomodulatory alkaloids |
| 05/07/2009 | US20090117079 Methods and materials for treating or preventing diseases/disorders mediated by alcohol dehydrogenase |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117076 Methods For Treating Tumor Cells |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090117072 Treatment of periodontal disease |
| 05/07/2009 | US20090117070 Methods and Crosslinked Polymer Compositions for Cartilage Repair |
| 05/07/2009 | US20090117064 Stable vitamin b6 derivative |
| 05/07/2009 | US20090117063 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) |
| 05/07/2009 | US20090117061 Skin care products containing multiple enhancers |
| 05/07/2009 | US20090117059 Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extracts thereof in combination with a steroid |
| 05/07/2009 | US20090117057 Grape Polyphenolics for Platelet and Bacterial Control |
| 05/07/2009 | US20090117054 Sublingual spray for the treatment of pain |
| 05/07/2009 | US20090117053 Local delivery of 5-aminolevulinic-acid based compounds to tissues and organs for diagnostic and therapeutic purposes |
| 05/07/2009 | US20090117046 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | US20090117031 Methods for Treating Glioma |
| 05/07/2009 | DE102008003054A1 Verwendungen von 2-(Piperidinyl)methyl-2,3-dihydroimidazo(1,2-c)chinazolin-5(6H)-on zum Bereitstellen einer analgetischen Wirkung, antiallergischen Wirkung und Histamin-H1-Rezeptorantagonismuswirkung Uses of 2- (piperidinyl) methyl-2,3-dihydroimidazo (1,2-c) quinazolin-5 (6H) -one for providing an analgesic effect, anti-allergic action and Histamine H1 receptor antagonism effect |
| 05/07/2009 | DE102007052870A1 Verwendung von Polyethylenglykol-Pulvern und Zusammensetzungen enthaltend diese Use of polyethylene glycol and compositions comprising these powders |
| 05/07/2009 | DE102007052119A1 New coumermycin A1-derivative, useful as biologically active substance and as antibiotics or cytostatics, and for preventing diseases caused by bacteria or tumor |
| 05/07/2009 | DE102007052071A1 Stabilisiertes Atorvastatin Stabilized atorvastatin |
| 05/07/2009 | DE102007052070A1 Candesartancilexetil Candesartancilexetil |
| 05/07/2009 | DE102007051762A1 Substituierte Pyrrolotriazine und ihre Verwendung Substituted Pyrrolotriazine and their use |
| 05/07/2009 | DE102007041656A1 Use of marker sequences for the diagnosis of rheumatoid arthritis, where the marker sequences of a complementary DNA (cDNA) from the specific sequence is determined in a patient |
| 05/07/2009 | CA2742345A1 Hyperbranched polyglycerol for improving heart function |
| 05/07/2009 | CA2742252A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 05/07/2009 | CA2740310A1 Altered cadherin processing in tumor cells |
| 05/07/2009 | CA2732636A1 Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat |
| 05/07/2009 | CA2712970A1 Lipoxin a4 protection for retinal cells |
| 05/07/2009 | CA2707649A1 Methods of augmenting or repairing soft tissue |
| 05/07/2009 | CA2705465A1 Lipoxin a4 protection for cornea endothelial cells |
| 05/07/2009 | CA2704780A1 Method of treating vitamin b12 deficiency |
| 05/07/2009 | CA2704533A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | CA2704529A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | CA2704517A1 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer |
| 05/07/2009 | CA2704462A1 Beta-lactone compounds |
| 05/07/2009 | CA2704431A1 Cytokine inhibitors |
| 05/07/2009 | CA2704360A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 05/07/2009 | CA2704337A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2704320A1 Aryl-substituted bridged or fused diamines as modulators of leukotriene a4 hydrolase |
| 05/07/2009 | CA2704298A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | CA2704286A1 Medium-chain length fatty acids and glycerides as nephroprotection agents |
| 05/07/2009 | CA2704262A1 Ingestible film composition |
| 05/07/2009 | CA2704250A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | CA2704199A1 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 05/07/2009 | CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | CA2704124A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | CA2704116A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | CA2704043A1 Targeting micrornas for the treatment of liver cancer |
| 05/07/2009 | CA2703981A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 05/07/2009 | CA2703980A1 Diamido thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2703979A1 Heterocyclic ether and thioether derivatives and methods of use thereof |
| 05/07/2009 | CA2703978A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2703971A1 Stabilized pediatric suspension of carisbamate |
| 05/07/2009 | CA2703918A1 Novel antiretroviral combination |
| 05/07/2009 | CA2703915A1 P2x3 receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703904A1 Substituted diazepan orexin receptor antagonists |
| 05/07/2009 | CA2703848A1 Non-anticoagulant polysaccharide compositions |
| 05/07/2009 | CA2703838A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | CA2703780A1 Drug for prophylaxis or treatment of cancer |
| 05/07/2009 | CA2703767A1 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/07/2009 | CA2703693A1 Anti-fatigue agent comprising amino acid composition |
| 05/07/2009 | CA2703683A1 Novel nacl salt substitute, use thereof and products containing same |
| 05/07/2009 | CA2703257A1 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | CA2703240A1 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | CA2703217A1 Antidiabetic tricyclic compounds |
| 05/07/2009 | CA2703063A1 Compositions for treating parkinson's disease |
| 05/07/2009 | CA2702761A1 Non-aqueous water-miscible materials as vehicles for drug delivery |
| 05/07/2009 | CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | CA2702535A1 Novel r,r'-atracurium salts |
| 05/07/2009 | CA2702320A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | CA2702256A1 Dispiro 1,2,4-trioxolane antimalarials |
| 05/07/2009 | CA2702134A1 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 05/07/2009 | CA2701703A1 Topical composition |
| 05/07/2009 | CA2700917A1 Novel pyrimidine derivatives |
| 05/07/2009 | CA2699889A1 4,4-disubstituted piperdines |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |